proton pump inhibitors PPT

SEMINAR ON PROTON PUMP INHIBITORS. SUBMITTED BY AVS.PRAVEEN KUMAR 07P25R0005. UNDER THEGUIDENCE OF Mr. K.SURENDRA Assistant professor,M.Pharm, RAO’S COLLEGE OF PHARMACY

PEPTIC ULCER . ,[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

ANTI ULCER DRUGS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

PROTON PUMP INHIBITORS DRUG OF CHOICE ,[object Object],[object Object],[object Object],[object Object],[object Object]

Omeprazole. The proton pump inhibitor OMEPRAZOLE

OMEPRAZOLE . Systematic ( IUPAC ) name 6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl)-1 H -benzo[ d ]imidazole Chemical data Formula C 17 H 19 N 3 O 3 S Mol. mass 345.4 g/mol Pharmacokinetic data Bioavailability 35–60% Metabolism Hepatic ( CYP2C19 , CYP3A4 ) Half life 1 - 1.2 hours Excretion 80% Renal 20% Faecal Therapeutic considerations Routes Oral, IV

PHARMACO K INETICS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

METABOLISM ,[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MECHANISM OF ACTION OF OMEPRAZOLE ,[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Omeprazole 20 mg, Capsules Omeprazole 10 mg, Capsules OMEZ :10, 20, 40,mg capsules. PROTOLOC :20, 40,mg capsules. ,[object Object]

OTHER DRUGS ,[object Object],[object Object],[object Object],[object Object]

REFFERENCE Essentials of medical pharmacology, by KD. Thripathi. Pharmacology & pharmaco therapeutics, by R.S. satoshkar. Text book of medical pharmacology, by Padmaja uday kumar. Pharmacology & clinical pharmaco kinetics, by G. Kutzung. Www. Proton pump inhibitor wikipedia, the free encyclopedia.

proton pump inhibitors PPT

Recomendados

Recomendados

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Destacado

Destacado (20)

Similar a proton pump inhibitors PPT

Similar a proton pump inhibitors PPT (20)

Más de pharmastuffblogspotcom

Más de pharmastuffblogspotcom (7)

Último

Último (20)

proton pump inhibitors PPT